Angiogensis models using nestin-expressing stem cells to image nascent blood vessels
    2.
    发明授权
    Angiogensis models using nestin-expressing stem cells to image nascent blood vessels 失效
    使用巢蛋白表达干细胞来形成新生血管的血管生成模型

    公开(公告)号:US08778308B2

    公开(公告)日:2014-07-15

    申请号:US10977219

    申请日:2004-10-28

    IPC分类号: A61B5/00 G01N21/64 G01N33/50

    CPC分类号: G01N33/5073

    摘要: The disclosed invention relates to the observation that nestin expression is a marker for endothelial cell proliferation. Nestin expression is particularly useful as a marker for angiogenesis, particularly for tumor-related angiogenesis. Specifically, nestin serves as an excellent endothelium marker for brain tumors such as gliomas, hemangioblastomas, Schwannomas, medulloblastomas, and meningiomas. Accordingly, the disclosed invention relates to the use of this marker as a basis to model angiogenic activity.

    摘要翻译: 所公开的发明涉及巢蛋白表达是内皮细胞增殖的标志物的观察。 巢蛋白表达特别可用作血管发生的标志物,特别是肿瘤相关血管发生。 具体来说,巢蛋白作为脑肿瘤如胶质瘤,血管母细胞瘤,神经鞘瘤,成神经管细胞瘤和脑膜瘤的优异内皮标志物。 因此,所公开的发明涉及该标记物作为模型血管生成活性的基础的用途。

    Angiogensis models using nestin-expressing stem cells to image nascent blood vessels
    3.
    发明申请
    Angiogensis models using nestin-expressing stem cells to image nascent blood vessels 失效
    使用巢蛋白表达干细胞来形成新生血管的血管生成模型

    公开(公告)号:US20050170330A1

    公开(公告)日:2005-08-04

    申请号:US10977219

    申请日:2004-10-28

    CPC分类号: G01N33/5073

    摘要: The disclosed invention relates to the observation that nestin expression is a marker for endothelial cell proliferation. Nestin expression is particularly useful as a marker for angiogenesis, particularly for tumor-related angiogenesis. Specifically, nestin serves as an excellent endothelium marker for brain tumors such as gliomas, hemangioblastomas, Schwannomas, medulloblastomas, and meningiomas. Accordingly, the disclosed invention relates to the use of this marker as a basis to model angiogenic activity.

    摘要翻译: 所公开的发明涉及巢蛋白表达是内皮细胞增殖的标志物的观察。 巢蛋白表达特别可用作血管发生的标志物,特别是肿瘤相关血管发生。 具体来说,巢蛋白作为脑肿瘤如胶质瘤,血管母细胞瘤,神经鞘瘤,成神经管细胞瘤和脑膜瘤的优异内皮标志物。 因此,所公开的发明涉及该标记物作为模型血管生成活性的基础的用途。